Li Xiao

机构：Guangdong Pharmaceutical University · ORCID：0000-0001-8084-1384

发表论文 51 篇 · 总被引 3353 次 · h-index 27

代表论文

• Design of an in vitro biocatalytic cascade for the manufacture of islatravir (2019 · Science · 被引 649)
• Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation (2021 · Nature Communications · 被引 125)
• Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting (2017 · Cell chemical biology · 被引 92)
• Engineering Hydroxylase Activity, Selectivity, and Stability for a Scalable Concise Synthesis of a Key Intermediate to Belzutifan (2024 · Angewandte Chemie International Edition · 被引 56)
• MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology (2018 · ACS Medicinal Chemistry Letters · 被引 53)
• Genistein-3′-sodium sulfonate Attenuates Neuroinflammation in Stroke Rats by Down-Regulating Microglial M1 Polarization through α7nAChR-NF-κB Signaling Pathway (2021 · International Journal of Biological Sciences · 被引 52)